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(57) ABSTRACT 
This invention involves method and apparatus for guiding 
ablative therapy of abnormal biological electrical excitation. 
In particular, it is designed for treatment of cardiac arrhyth- 
mias. In the method of this invention electrical signals are 
acquired from passive electrodes, and an inverse dipole 
method is used to identify the site of origin of an arrhytmia. 
The location of the tip of the ablation catheter is similarly 
localized from signals acquired from the passive electrodes 
while electrical energy is delivered to the tip of the catheter. 
The catheter tip is then guided to the site of origin of the 
arrhythmia, and ablative radio frequency energy is delivered 
to its tip to ablate the site. 
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METHOD AND APPARATUS FOR GUIDING 
ABLATIVE THERAPY OF ABNORMAL 
BIOLOGICAL ELECTRICAL EXCITATION 
This invention was made with government support under 
Grant Number NAGS-4989 awarded by the NASA. The 
government has certain rights to this invention. 
BACKGROUND OF THE INVENTION 
The electrical activity generated in certain organs in the 
human body is intimately related to their function. Abnor- 
malities in cardiac and brain electrical conduction processes 
are principal causes of morbidity and mortality in the 
developed world. Appropriate treatment of disorders arising 
from such abnormalities frequently requires a determination 
of their location. Such localization of the site of origin of an 
abnormal electrical excitation is typically achieved by pains- 
taking mapping of the electrical activity on the inner surface 
of the heart or the brain from electrodes or a catheter. Often, 
this recording must be done while the abnormal biological 
electrical excitation is ongoing. 
Radio frequency catheter ablation procedures have 
evolved in recent years to become an established treatment 
for patients with a variety of supraventricular [Lee, 1991; 
Langberg, 19931 and ventricular arrhythmias [Stevenson, 
1997; Stevenson, 19981. However, in contrast to supraven- 
tricular tachycardia ablation, which is highly successful 
because the atrio-ventricular node anatomy is known, ven- 
tricular tachycardia ablation remains difficult because the 
site of origin of the arrhythmia could be anywhere in the 
ventricles. 
Sustained ventricular tachycardia is often a difficult 
arrhythmia to manage. One of the most common indications 
for radio frequency catheter ablation of ventricular tachy- 
cardia is arrhythmia refractory to drug therapy that results in 
frequent discharges from an implantable cardioverter- 
defibrillator. Radio frequency ablation is also indicated 
when the VT is too slow to be detected by the implantable 
cardioverter-defibrillator or is incessant [Strickberger, 
19971. 
Selection of the appropriate target sites for ablation is 
usually based on a combination of anatomical and electrical 
criteria. The ability of the physician to deliver radio- 
frequency energy through a catheter at the reentry site is 
restricted by the limitations of the current technology to that 
is employed to guide the catheter to the appropriate ablation 
site. The principal limitation of the radio frequency ablation 
technique is the determination of the correct site for delivery 
of the radio frequency energy. Conventionally, this determi- 
nation is achieved by painstaking mapping of the electrical 
activity on the inner surface of the heart from electrodes on 
the catheter. Often, this recording must be done while the 
arrhythmia is ongoing. This is a major problem, especially 
for those arrhythmias which compromise hemodynamic 
function of the patient. Many arrhythmias for this reason are 
not presently amenable to radio frequency ablation treat- 
ment. 
The acute lesion created by radio frequency current 
consists of a central zone of coagulation necrosis surrounded 
by a zone of hemorrhage and inflammation. Arrhythmias 
may recur if the target tissue is in the border zone of a lesion 
instead of in the central area of necrosis. If the inflammation 
resolves without residual necrosis, arrhythmias may recur 
several days to several weeks after an apparently successful 
ablation [Langberg, 19921. Conversely, an arrhythmia site of 
origin that was not initially successfully ablated may later 
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become permanently nonfunctional if it lies within the 
border zone of a lesion and if microvascular injury and 
inflammation within this zone result in progressive necrosis 
[Nath, 19941. Thus, the efficacy and long term outcome of 
catheter ablation depend on accurate determination of the 
site of origin of the arrhythmia. 
Catheter ablation of sustained monomorphic ventricular 
tachycardia (VT) late after myocardial infarction has been 
challenging. These arrhythmias arise from reentry circuits 
that can be large and complex, with broad paths and narrow 
isthmuses, and that may traverse subendocardial, intramural, 
and epicardial regions of the myocardium [deBakker, 1991; 
Kaltenbrunner, 199 11. 
Mapping and ablation are further complicated by the 
frequent presence of multiple reentry circuits, giving rise to 
several morphologically different VTs [Wilbur, 1987; 
Waspel, 19851. In some cases, different reentry circuits form 
in the same abnormal region. In other cases, reentry circuits 
form at disparate sites in the infarct area. The presence of 
multiple morphologies of inducible or spontaneous VT has 
been associated with antiarrhythmic drug inefficacy 
[Mitrani, 19931 and failure of surgical ablation [Miller, 
19841. 
Several investigators have reported series of studies of 
patients selected for having one predominant morphology of 
VT (“clinical VT”) who were treated with radio frequency 
catheter ablation [Morady, 1993; Kim, 19941. It is likely that 
this group of patients represents less than 10% of the total 
population of patients with VT [Kim, 19941. The patient 
must remain hemodynamically stable while the arrhythmia 
is induced and maintained during mapping. The mapping 
procedure may take many hours during which the arrhyth- 
mia must be maintained. Thus, currently radio frequency 
catheter ablation is generally limited to “slow” ventricular 
tachycardia (-130 bpm) which is most likely to be hemo- 
dynamically stable. 
Ablation directed towards the “clinical tachycardia” that 
did not target other inducible VTs successfully abolished the 
“clinical VT” in 71% to 76% cases. However, during 
followup up to 31% of those patients with successful abla- 
tion of the “clinical VT” had arrhythmic recurrences, some 
of which were due to different VT morphologies from that 
initially targeted for ablation. 
Furthermore, there are several difficulties in selecting a 
dominant, “clinical VT” for ablation. Often it is not possible 
to determine which VT is in fact the one that has occurred 
spontaneously. In most cases, only a limited recording of one 
or a few ECG leads may be available. In patients with 
implantable defibrillators VT is typically terminated by the 
device before an ECG is obtained. Even if one VT is 
identified as predominant, other VTs that are inducible may 
subsequently occur spontaneously. An alternative approach 
is not to consider the number of VT morphologies in 
determining eligibility for catheter ablation but rather to 
attempt ablation of all inducible VTs that are sufficiently 
tolerated to allow mapping [Stevenson, 1998b; Stevenson, 
19971. However, this approach requires that the patient be 
hemodynamically stable during the VT mapping procedure. 
The use of fluoroscopy (digital bi-plane x-ray) for the 
guidance of the ablation catheter for the delivery of the 
curative radio frequency energy is common to clinical 
catheter ablation strategies. However, the use of fluoroscopy 
for these purposes may be problematic for the following 
reasons: (1) It may not be possible to accurately associate 
intracardiac electrograms with their precise location within 
the heart; (2) The endocardial surface is not visible using 
3 
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fluoroscopy, and the target sites can only be approximated 
by their relationship with nearby structures such as ribs and 
blood vessels as well as the position of other catheters; (3) 
Due to the limitations of two-dimensional fluoroscopy, navi- 
gation is frequently inexact, time consuming, and requires 
multiple views to estimate the three-dimensional location of 
the catheter; (4) It may not be possible to accurately return 
the catheter precisely to a previously mapped site; (5) It is 
desirable to minimize exposure of the patient and medical 
personnel to radiation; and (6) Most importantly, fluoros- 
copy cannot identify the site of origin of an arrhythmia and 
thus cannot be used to specifically direct a catheter to that 
site. 
Electro-anatomic mapping systems (e.g., Carto, Biosense, 
Marlton, N.J.) provide an electro-anatomical map of the 
heart. This method of nonfluoroscopic catheter mapping is 
based on an activation sequence to track and localize the tip 
of the mapping catheter by magnetic localization in con- 
junction with electrical activity recorded by the catheter. 
This approach has been used in ventricular tachyardia 
[Nademanee, 1998; Stevenson, 19981, atrial flutter [Shah, 
1997; NakagawaJ9981, and atrial tachycardia ablation 
[Natale, 1998; Kottkamp, 19971. The ability to localize in 
space the tip of the catheter while simultaneously measuring 
the electrical activity may facilitate the mapping process. 
However, this technique fundamentally has the limitation 
that it involves sequentially sampling endocardial sites. The 
mapping process is prolonged while the patients must be 
maintained in VT. Also, the localization is limited to the 
endocardial surface and thus sites of origin within the 
myocardium cannot be accurately localized. 
The basket catheter technique employs a non-contact 
64-electrode basket catheter (Endocardial Solutions Inc., St. 
Paul, Minn.) placed inside the heart to electrically map the 
heart. In the first part of this procedure high frequency 
current pulses are applied to a standard catheter used in an 
ablation procedure. The tip of this catheter is dragged over 
the endocardial surface, and a basket catheter is used to 
locate the tip of the ablation catheter and thus to trace and 
reconstruct the endocardial surface of the ventricular cham- 
ber. Then the chamber geometry, the known locations of the 
basket catheter, and the non-contact potential at each elec- 
trode on the basket catheter are combined in solving 
Laplace’s equation, and electrograms on the endocardial 
surface are computed. This technique has been used in 
mapping atrial and ventricular arrhythmias [Schilling, 1998; 
Gornick, 19991. One of the drawbacks of this methodology 
is that the ventricular geometry is not fixed but varies during 
the cardiac cycle. In addition, the relative movement 
between the constantly contracting heart and the electrodes 
affects the mapping. While the inter-electrode distances on 
each sidearm of the basket catheter are fixed, the distances 
between the actual recording sites on the endocardium 
decrease during systole. This leads to relative movement 
between the recording electrode and the tissue, significantly 
limiting the accuracy of the mapping method. Also, the 
localization is limited to the endocardial surface, and thus 
sites of origin within the myocardium cannot be accurately 
localized. 
What is needed is a means of efficiently directing the tip 
of a catheter to a site of origin of an arrhythmia in the heart 
(whether on the endocardial surface or within the myocar- 
dium itself), without the need to introduce additional passive 
electrodes into the heart, so that energy can be delivered 
through the catheter to ablate the site of origin. It would be 
advantageous to be able to accomplish this task without 
having to maintain the arrhythmia while advancing the 
catheter to the site of origin, so that the patient does not 
suffer the ill effects of the arrhythmia for a prolonged period. 
This consideration is particularly important in the case of 
rapid arrhythmias that compromise hemodynamic function. 
SUMMARY OF THE INVENTION 
5 
The present invention provides methods and apparatus for 
localizing an electrical source within the body. The inven- 
tion further provides methods and apparatus for delivering 
lo ablative electrical energy in the vicinity of an electrical 
source within the body. The electrical source may be located 
anywhere within the body. For example, the electrical source 
may be within the heart and may be the site of origin of a 
cardiac arrhythmia. The electrical source may be a focus of 
electrical activity within the brain, such as a site involved in 
triggering an epileptic seizure, or may be located in other 
neurological tissue. 
Cardiac arrhythmias are frequently treated by delivering 
electrical energy to the site of origin of the arrhythmia in an 
2o effort to ablate the site. To effectively perform this 
procedure, accurate localization of both the site of origin of 
the arrhythmia and the energy delivery device (e.g., the tip 
of a catheter) are necessary. As used herein, the term 
“localization” refers to determining either an absolute or a 
2s relative location. The present invention provides techniques 
for accurately performing such localization. The minimally 
invasive and fast aspects of certain embodiments of the 
invention, as disclosed herein, are particularly important. 
In preferred embodiments the methods of the present 
invention involve placing passive electrodes on the body 
surface, placing active electrode(s) in and/or on the body, 
acquiring from the passive electrodes signals emanating 
from the electrical source, processing the signals emanating 
3s from the electrical source to determine the relative location 
of the electrical source, delivering electrical energy to the 
active electrode(s), acquiring from the passive electrodes the 
signals emanating from the active electrode(s), processing 
the signals emanating from the active electrode(s) to deter- 
4o mine the relative location of the active electrode(s), and 
positioning the active electrode(s) to localize the electrical 
source. In another embodiment at least one of the passive 
electrodes is placed within the body, for example within the 
heart. The positioning step of the present invention may 
involve approximating the relative locations of the active 
electrode(s) and the electrical source. In preferred embodi- 
ments of the method the energy delivering step, the second 
acquiring step, the second processing step and the position- 
ing step are performed iteratively. 
In a preferred embodiment the first processing step is used 
to determine the relative location of the electrical source at 
a multiplicity of time epochs during the cardiac cycle, and 
the positioning step localizes the electrical source at one of 
the time epochs. At least one criterion may be used to choose 
ss the time epoch. In a particularly preferred embodiment at 
least one of the processing steps involves fitting the acquired 
signals to a moving dipole model. 
Another preferred embodiment of the invention involves 
delivering ablative energy in the vicinity of the location of 
60 an electrical source within the body by delivering ablative 
energy in the vicinity of the location of the active electrode 
(s) .  The active electrode(s) may be located on a catheter, and 
the ablative energy may be delivered through the catheter. In 
a preferred embodiment the ablative energy is radio fre- 
The methods of the present invention may further include 
displaying various parameters. Among the parameters of 
30 . 
4s 
so 
65 quency energy. 
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interest are the relative location of the electrical source and a few beats of the arrhythmia, thereby eliminating the need 
measures of the size, strength, and/or uncertainty in the for prolonged maintenance of the arrhythmia during the 
relative location of the electrical source. localization process. In addition, if one delivers low- 
Other features and advantages of the invention will amplitude bipolar current pulses to the tip of an ablation 
become apparent from the following description, including 5 catheter and acquires the body surface the 
tip of the catheter may likewise be modeled as a single the drawing, and from the claims. equivalent moving dipole. Therefore, the same inverse algo- 
rithm may be employed to localize the tip of the catheter. 
Using this information one can guide the tip of the catheter 
FIG. 1 is a flow chart of the method for localizing an to the site of origin of the arrhythmia. 
electrical source within the body. The confounding factors of the SEMD method involve the 
FIG, 2 is a flow chart of a procedure for fitting single fact that, as proposed herein, the method does not consider 
equivalent moving dipole parameters to ECG potentials, boundary conditions and inhomogeneities in tissue conduc- 
FIG, is a schematic diagram of an apparatus for local- tivity. Furthermore, even the exact position of the passive 
izing a site of origin of an arrhythmia, guiding the delivery 15 acquiring electrodes in three-dimensional space may not be 
of ablative therapy, and delivering ablative therapy to the accurately determined. Thus the inverse solution obtained is 
distorted. However, as long as the site of origin of the site of origin of the arrhythmia. 
arrhythmia and the tip of the catheter are identified using the 
same algorithm, then when the two are brought together, 
2o both their positions will be distorted by the same amount. In 
other words, when the algorithm identifies that the site of 
The Present invention encompasses the finding that by origin of the arrhythmia and the catheter tip are at the same 
employing a moving dipole model it is Possible to accurately location, then they are at the same location. Thus the 
localize a source of electrical energy within the body relative distortion due to the above factors should not significantly 
to the location of an active electrode. If one can localize the 25 affect the accuracy by which one can make the tip of the 
site of origin of an arrhythmia during the cardiac cycle, it is ablation catheter and the site of origin of the arrhythmia 
Possible to ablate the site through delivery of ablative coincide. Therefore, although the SEMD method described 
electrical energy. The Present invention Provides methods herein may not establish the absolute locations of the site of 
and apparatus for localizing an electrical source within the origin of the arrhythmia and the tiP of the catheter, it can 
body. The invention further provides methods and apparatus 3o effectively identify their relative locations, 
for localizing and ablating the site of origin of a cardiac FIG, 1 shows a flowchart of the method according to the 
arrhythmia. present invention for localizing an electrical source within 
The concept of considering the heart as a single dipole the body. The method includes placing passive electrodes in 
generator originated with Einthoven [Einthoven, 19121, and or on the body to acquire electrical signals. The signals from 
its mathematical basis was established by Gabor and Nelson 35 the passive electrodes are processed to determine the relative 
[Gabor, 19-54]. Several investigators [Mirvis, 1981; location of the electrical source within a given short time 
Gulrajani, 19841, [Tsunakawa, 19871 have studied the car- epoch. The processing steps are repeated for multiple 
diac dipole in clinical practice and attempted to determine sequential time epochs, and the location of the Source 
the dipolar nature of the ECG. The advantages of the use of corresponding to the site of the origin of the arrhythmia is 
the equivalent cardiac dipole are: (1) It permits quantifica- 4o obtained. As used herein, the phrase ‘‘sequential time 
tion of source strength in biophysical terms that are inde- epochs” does not necessarily imply immediately successive 
p e n d e n t  of  v o l u m e  c o n d u c t o r  s i z e  ( c l a s s i c  time epochs. 
electrocardiograPhY), and (2) The active equivalent Source As further shown in FIG. 1, electrical energy is delivered 
can be localized and assigned a location, something that from at least one active electrode placed within or on the 
cannot be done using classical electrocardiography. 45 body, and the signals emanating from the at least one active 
For many arrhythmias, the electrical activity within the electrode (e.g., at the tip of a catheter) are acquired from the 
heart is highly localized for a portion of the cardiac cycle. passive electrodes. Signals emanating from the at least one 
During the remainder of the cardiac cycle the electrical active electrode are processed to determine the relative 
activity may become more diffuse as the waves of electrical location of the at least one active electrode within a given 
activity spread. It is not possible to construct the three- 50 short time epoch. Thereafter, the processes of delivering 
dimensional distribution of cardiac electrical sources from a electrical energy and determining the relative location of at 
two-dimensional distribution of ECG signals obtained on least one active electrode are repeated until the active 
the body surface. However, if it is known that a source is electrode is superposed to the relative location of the elec- 
localized, then this localized source can be approximated as trical source. In other words, the processes of delivering 
a single equivalent moving dipole (SEMD), for which one 5s electrical energy to the at least one active electrode, acquir- 
can compute the dipole parameters (i.e., location and ing from the passive electrodes the signals emanating from 
moments) by processing electrocardiographic signals the at least one active electrode, processing the signals 
acquired from passive electrodes placed on the body surface emanating from the at least one active electrode, and posi- 
or in the body. tioning the at least one active electrode are performed 
Fitting the dipole parameters to body surface ECG signals 60 iteratively. This repetition of steps 4 through 7 of FIG. 1 may 
provides a solution (referred to herein as the inverse be terminated when the relative locations of the electrical 
solution) for the dipole location (as well as for its strength source and the active electrode are within a predetermined 
and orientation). The location of the dipole at the time epoch distance (not shown on FIG. 1). 
when the electrical activity is confined to the vicinity of the The present invention provides method and apparatus for 
site of origin of an arrhythmia should coincide with the site 65 guiding ablative therapy within an organ system either from 
of origin of the arrhythmia. In contrast to standard mapping body surface electrodes or from internal electrodes. This 
techniques, the inverse solution can be computed from only technique explicitly recognizes that one cannot uniquely 
BRIEF DESCRIPTION OF THE DRAWING 
DESCRIPTION OF PREFERRED 
EMBODIMENTS 
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reconstruct from a two-dimensional array of electrodes a 
three-dimensional distribution of sources. The present 
invention models bio-electrical activity as a single equiva- 
lent moving dipole (SEMD), which is a valid model when 
the bio-electrical activity is highly localized. In the cardiac 5 
provides a three-dimensional picture of cardiac electrical 
activity. - rL)(r; - 
The basic theory of the present invention derives from 
infinite homogeneous volume conductor is given by the 
equation below. # i ( r i - r i )  
and after substituting Eq. 1 into Eq. 3, we obtain 
2 p J E k J  = p k  
J=I 
context, the evolution of the SEMD during the cardiac cycle where 
EkJ = 
lrl - r1I6 
' = J  
electromagnetic theory. The potential due to a dipole in an and 
p k = c -  
,=I lri -r1l3 
p (r' - r') 0% 1) 15 
lrl - rq3 
#' = ~ 
Thus, the potential is now given by an equation of the form 
(+=$'(p(r'), r'), where p(r') represents the optimal dipole 
moment at the location r'. This equation can now be solved 
for all dipole moment components pk. 
a preferred embodiment of the invention the moving 
dipole model presented above is employed to localize a 
source of electrical activity within the body (e.g., a site of 
origin of a cardiac arrhythmia) and to localize at least one 
25 invention, passive electrodes are used to acquire ECG poten- 
tials from the body. Following data acquisition, each of the 
body surface ECG channels is examined to secure good data 
quality, Inadmissible data could occur, for example, due to 
(1) lack of contact of the electrodes to the skin or other body 
Following confirmation that the data quality is adequate, 
in preferred embodiments of the invention the data is 
preprocessed. In a preferred embodiment, the R wave in the 
QRS complex is identified in each ECG beat and for each 
35 channel and subsequently the baseline of each beat is 
adjusted relative to an identified PR segment. Baseline 
correction includes estimation of the baseline in the isoelec- 
tric PR segment by averaging successive samples in this 
(+ is the potential at the i, electrode because of the time window for each lead and subsequently subtracting this 
40 estimate before construction of the vector magnitude. The 
wrn is the measured potential at the i, electrode, resulting annotations and RR intervals may be displayed and 
graphically examined for evidence of spurious and/or unde- 0" is a noise measurement at the i, electrode, tected events. Then, fiducial points are determined by an 
adaptive QRS template matching scheme to refine initial I is the number of electrodes 
Because Of the linear dependence Of the potentia' (Eq. '1 4s fiducial point estimates. For this refinement phase the vector 
where, 
r' is the three-dimensional vector representing the i, 2o 
p is the three-dimensional vector representing the dipole 
observation location, 
moment, and 
location. 
rl  is the three-dimensional vector representing the dipole active (e.g., the tip Of a catheter). According to the 
One may obtain the dipole parameters, i.e., p and r', from 
potential measurements through minimization of an objec- 
tive function. One may use chi-square (x') as the objective 
function to obtain the dipole parameter estimates. x' is given 3o tissue, or (2) electrode failure during the procedure, 
by equation 2 below: 
(Eq 2, 
,=I 
where 
specific dipole components, 
on the dipole moment parameters, the latter can be separated magnitude waveform of the QRS complex from standard 
from the dipo1e parameters. any Opti- ECG leads (I, 11, 111) is calculated for each beat. This is 
mization method may be parameters performed by calculating the square root of the sum of the 
Only, an Optimization procedure may be squares of each of the three baseline-corrected standard 
performed to Obtain the Optimal fitting dipo1e moment 50 leads. The average vector magnitude QRS complex is then 
parameters for a specific set Of dipo1e parameters. we calculated with the use of initial fiducial point estimates, 
coin the term Plus parameter Optimization for this With this average as a template, the fiducial points corre- 
Using the x' as an Objective function the Optimal dipo1e cross-correlation between each beat and the template 
to the 
sponding to each QRS complex are shifted to maximize the 
P Y ~  pz) at each dipo1e location can ss [Smith, 19881. Next, a median beat is created to represent 
each data segment by aligning each beat within the data 
algorithm. 
moment components 
be obtained by solving the following system of equations: 
o = -  ax2 
a P k  
segment according to the R -wave, and identifying the 
median value on a time epoch-by-time epoch basis within 
the beat. After estimation of the median beat for each 
60 channel, a noise estimate will be obtained from each median 
beat (and channel) in a predefined noise window. 
After completion of the preprocessing of the data, an 
algorithm to fit the single equivalent moving dipole (SEMD) 
parameters to the ECG potentials is applied for every time 
65 epoch in the cardiac cycle. In a preferred embodiment of the 
invention the algorithm shown in FIG. 2 is employed. This 
algorithm utilizes a multiple seed value search (e.g., a 
(Eq, 3) 
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maximum of ten seeds). A spatial criterion is imposed to 
eliminate solutions that land outside a predefined volume 
(e.g., the volume of the body). The distance, D,, between the 
location of the solution resulting from each seed (i.e., the 
current location) and the location of the best previous 
solution is determined. If the distance (D,) is not less than 
0.1 cm and the x’ of the current solution (x’,,,) is less than 
the x’ of the best solution obtained thus far ( ~ ’ ~ ~ ~ ~ 4 9 7 )  then 
the current solution becomes the new best solution. 
Alternatively, if D,<0.1 cm then the final solution is set to 
whichever of either the current solution or the best previous 
solutions has the lower x’. The algorithm is terminated when 
two solutions are found to be closer than approximately 0.1 
cm. Note that the two solutions need not necessarily be 
successive solutions. A solution obtained for a particular 
time epoch in a given cardiac cycle serves as the initial seed 
for the next time epoch. If, after all seeds are used, no 
solutions have been found within a given time epoch that 
satisfy the spatial criterion and are closer together than 
approximately 0.1 cm, the algorithm outcome will be con- 
sidered nonconvergent for that time epoch. 
In another embodiment, an algorithm able to perform 
beat-to-beat analysis (continuous analysis) across all chan- 
nels can be employed in the processing step. This algorithm 
has the ability to select a baseline segment before each QRS 
complex for individual beat noise estimation. Since, for each 
time epoch, the algorithm obtains N solutions that corre- 
spond to the best solutions of the same time epoch for the N 
beats, the selection of the solution with the smallest error in 
predicting the potentials measured on the electrodes is 
chosen to be the best solution for that time epoch. 
In a preferred embodiment of the present invention the 
3-point derivative and the maximum absolute value of the 
slope given by equation 7 below will be used to identify the 
earliest activation in the surface unipolar ECG signal, to 
identify the time epoch during the cardiac cycle that corre- 
sponds to the first indication of the site of the origin of the 
arrhythmia on the body surface 
5 
10 
1s 
20 
2s 
30 
3s 
component of the signal due to the catheter tip signal, while 
leaving that component of the signal due to bio-electrical 
activity unaltered. 
The catheter signal amplitude is chosen such that it is 
sufficiently low (e.g., less than 10 microamperes) that it will 
not induce unwanted bio-electric activity, yet high enough 
that it can be readily detected. The catheter signal frequency 
is sufficiently high that it lies far outside the bandwidth of 
the bio-electric signal of interest. At the same time, the 
catheter signal frequency is not so high that the frequency- 
dependent tissue impedance will differ significantly between 
the catheter frequency and the bio-electric signal frequency. 
A typical frequency is approximately 5 kHz. It should be 
understood that numerical values for the catheter signal 
amplitude and frequency are presented for illustrative pur- 
poses and are not intended to limit the scope of the inven- 
tion. 
FIG. 3 shows a preferred embodiment of the apparatus for 
localizing an electrical source (e.g., the site of origin of an 
arrhythmia) within the heart, guiding the delivery of ablative 
energy, and delivering ablative energy to the vicinity of the 
electrical source. A multiplicity of passive electrodes are 
placed on the body surface of a subject (0) such that the heart 
may be viewed from the anterior, left lateral, right lateral, 
and posterior chest. Each electrode position is provided by 
the operator to the analysis software. 
Signals from the passive electrodes (1) are carried in a 
multi-lead cable (2) through an isolation amplifier (3) to an 
amplifier bank (4) with adjustable gain and frequency 
response. A lock-in amplifier (5 )  is used to identify signals 
that are generated by the signal generator, emanate from the 
active electrode(s), and are acquired from the passive elec- 
trodes. A low-pass filter (6) is used to identify signals 
acquired from the passive electrodes that arise due to 
bio-electrical activity within the body. A computer (7) 
equipped with a multiplexor and an analog to digital con- 
version card digitizes and processes the signals emanating 
from a bio-electrical source within the body and the signals 
emanating from the active electrode. As described in ietail 
processing step utilizes a single equivalent moving dipole 
(SEMD) model to localize both the bio-electrical source and 
where SI is the sampling interval. the active electrode at a series of time epochs. The computer 
The same model and algorithm used to identify the region also creates an electronic representation of the signals 
of localized electrical activity in the organism are also used 4s acquired from each electrode, stores the signals, and dis- 
to identify the location of the tip of the catheter. An plays the signals on a display (12). To inspect the signals the 
oscillatory low amplitude electrical signal is applied at the operator may display them off-line from storage at a rate 
catheter tip, which permits the invention to discriminate slower than real time. The position, magnitude, and orien- 
between the catheter signal and the bio-electric signal. The tation of the SEMD attributed to cardiac electrical activity at 
signal from each electrode in the body is a sum of two SO each time epoch are displayed in a three-dimensional view 
components: the low frequency bio-electric signal and the of the heart. The uncertainty in the position of the SEMD 
high frequency catheter tip signal. The invention preferably and the goodness-of-fit value of the estimation of the SEMD 
utilizes a low-pass filter to select that component of the parameters may also be displayed for each time epoch. 
signal originating from bio-electric activity and a lock-in The ablation catheter (9) with its at least one active 
amplifier to select that component of the signal originating ss electrode is placed in the heart (8) of the subject. The 
from the catheter tip signal. catheter is connected through a high-voltage isolation stage 
The lock-in amplifier demodulates the signal from each (10) that serves as an automatic switch (the switch auto- 
electrode by the known catheter tip signal. This process has matically turns off the signal generator circuit after sensing 
two consequences: (1) The effects of the bio-electric signal the radiofrequency source) to a signal generator ( l l ) ,  which 
are removed, and (2) The signal from the catheter tip is 60 is controlled by the computer. The position, magnitude, and 
altered so that it can be treated as a simple direct current orientation of the dipole attributed to the tip of the catheter 
(DC) dipole in the same manner as the bio-electric signal. are displayed for each time epoch. The uncertainty in the 
In order to detect the bio-electric signal of interest in position of the dipole attributed to the tip of the catheter and 
preferred embodiments of the invention, the signal from the goodness-of-fit value of the estimation of the dipole 
each electrode is first low-pass filtered to remove the high- 65 parameters attributed to the tip of the catheter are also 
frequency signal due to the catheter tip. The low-pass filter displayed for each time epoch. Aradio frequency source (13) 
cut-off frequency is adjusted so that it will remove that controlled by the operator is also attached to the ablation 
- (Eq’7) 40 above, in a preferred embodiment of the invention the d V ( r d  - V@!+1) - V(rI-l) 
dr 2*SI 
US 6,308,093 B1 
11 12 
catheter. After localization of the source of abnormal elec- 
trical activity (i.e., the site of origin of the arrhythmia) and 
positioning of the tip of the catheter at the source of 
abnormal electrical activity as described above, the catheter 
is used to deliver ablative radio frequency energy to the s 
vicinity of the site of origin of the arrhythmia. 
It is recognized that modifications and variations of the 
present invention will occur to those skilled in the art, and 
it is intended that all such modifications and variations be 
included within the scope of the appended claims. 
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What is claimed is: 
1. A method for localizing an electrical source in the body 
placing passive electrodes on the body; 
placing at least one active electrode in the body; 
acquiring from the passive electrodes signals emanating 
processing the signals emanating from the electrical 
comprising: 
1s 
from the electrical source; 
source to determine the relative location of the electri- 2o 
cal source; 
electrode; 
delivering electrical energy to the at least one active 
acquiring from the passive electrodes the signals emanat- 
processing the signals emanating from the at least one 
active electrode to determine the relative location of the 
at least one active electrode; 
positioning the at least one active electrode to localize the 3o 
electrical source. 
2. A method for localizing an electrical source in the body 
placing passive electrodes on the body; 
acquiring from the passive electrodes signals emanating 
from the electrical source; 
processing the signals emanating from the electrical 
source to determine the relative location of the electri- 
cal source; 
delivering electrical energy to the at least one active 
electrode; 
acquiring from the passive electrodes the signals emanat- 
ing from the at least one active electrode; 
processing the signals emanating from the at least one 
active electrode to determine the relative location of the 
at least one active electrode; 
positioning the at least one active electrode to localize the 
electrical source. so 
3. A method for localizing an electrical source in the body 
placing passive electrodes in the body; 
placing at least one active electrode on the body; 
acquiring from the passive electrodes signals emanating ss 
from the electrical source; 
processing the signals emanating from the electrical 
source to determine the relative location of the electri- 
cal source; 
delivering electrical energy to the at least one active 
electrode; 
acquiring from the passive electrodes the signals emanat- 
ing from the at least one active electrode; 
processing the signals emanating from the at least one 65 
active electrode to determine the relative location of the 
at least one active electrode; 
ing from the at least one active electrode; 2s 
comprising: 
placing at least one active electrode on the body; 3s 
40 
4s 
comprising: 
60 
14 
positioning the at least one active electrode to localize the 
4. A method for localizing an electrical source in the body 
placing passive electrodes in the body; 
placing at least one active electrode in the body; 
acquiring from the passive electrodes signals emanating 
from the electrical source; 
processing the signals emanating from the electrical 
source to determine the relative location of the electri- 
cal source; 
delivering electrical energy to the at least one active 
electrode; 
acquiring from the passive electrodes the signals emanat- 
ing from the at least one active electrode; 
processing the signals emanating from the at least one 
active electrode to determine the relative location of the 
at least one active electrode; 
positioning the at least one active electrode to localize the 
electrical source. 
5 .  The method of claim 1, 2, 3, or 4 wherein the posi- 
tioning step involves approximating the relative locations of 
the at least one active electrode and the electrical source. 
6. The method of claim 1,2,3, or 4 wherein the delivering 
step, the second acquiring step, the second processing step, 
and the positioning step are performed iteratively. 
7. The method of claim 1,2,3,  or 4 wherein the electrical 
source is located in the heart. 
8. The method of claim 7 wherein the electrical source is 
the site of origin of an arrhythmia. 
9. The method of claim 7 wherein the first processing step 
is used to determine the relative location of the electrical 
source at a multiplicity of time epochs during the cardiac 
cycle. 
10. The method of claim 9 wherein the positioning step 
localizes the electrical source at one of the time epochs. 
11. The method of claim 10 wherein at least one criterion 
is used to choose the time epoch. 
12. The method of claim 1,2,3,  or 4 wherein at least one 
of the processing steps involves fitting the acquired signals 
to a moving dipole model. 
13. A method for delivering ablative energy in the vicinity 
of the location of an electrical source comprising the method 
of claim 1,2 ,3 ,  or 4 and further comprising the delivery of 
ablative energy in the vicinity of the location of the at least 
one active electrode. 
14. The method of claim 13 wherein the at least one active 
electrode is located on a catheter. 
15. The method of claim 14 wherein the ablative energy 
is delivered through the catheter. 
16. The method of claim 13 wherein the ablative energy 
is radio frequency electrical energy. 
17. The method of claim 1,2,3, or 4 wherein the electrical 
source is located in the brain. 
18. The method of claim 3 or claim 4 wherein at least one 
of the passive electrodes is placed within the heart. 
19. The method of claim 1, 2 ,3 ,  or 4 further comprising 
the displaying of the relative location of the electrical 
source. 
20. The method of claim 1, 2 ,3 ,  or 4 further comprising 
the displaying of at least one measure selected from the 
group consisting of a measure of the size of an electrical 
source, a measure of the strength of an electric source, and 
a measure of the uncertainty in the relative location of the 
electric source. 
21. A method for localizing an electrical source in the 
body comprising: 
electrical source. 
comprising: 
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placing passive electrodes on the body; 
placing at least one active electrode in the body; 
acquiring from the passive electrodes signals emanating 
from the electrical source; 
processing the signals emanating from the electrical 
source to determine the relative location of the electri- 
cal source at a multiplicity of time epochs during the 
cardiac cycle, wherein the processing involves fitting 
the signals to a moving dipole model; 
delivering electrical energy to the at least one active 
electrode; 
acquiring from the passive electrodes the signals emanat- 
ing from the at least one active electrode; 
processing the signals emanating from the at least one 
active electrode to determine the relative location of the 
at least one active electrode, wherein the processing 
involves fitting the signals to a moving dipole model; 
and 
positioning the at least one active electrode to localize the 
electrical source at one of the time epochs, wherein at 
least one criterion is used to choose the time epoch; and 
wherein the delivering step, the second acquiring step, 
the second processing step, and the positioning step are 
performed iteratively. 
22. Amethod for delivering ablative energy in the vicinity 
of the location of an electrical source comprising the method 
of claim 21 and further comprising the delivery of ablative 
energy in the vicinity of the location of the at least one active 
electrode, wherein the at least one active electrode is located 
on a catheter, wherein the ablative energy is delivered 
through the catheter, and wherein the electrical source is the 
site of origin of a cardiac arrhythmia. 
23. An apparatus for localizing an electrical source within 
the body comprising: 
at least one passive electrode adapted for placement on 
the body; 
at least one active electrode adapted for placement in the 
body; 
a signal generator for delivering electrical energy to the at 
least one active electrode; and 
a computer for processing the signals emanating from the 
electrical source and the at least one active electrode to 
determine the relative location of the electrical source 
and the relative location of the at least one active 
electrode. 
24. An apparatus for localizing an electrical source within 
at least one passive electrode adapted for placement on 
the body; 
at least one active electrode adapted for placement on the 
body; 
a signal generator for delivering electrical energy to the at 
least one active electrode; and 
a computer for processing the signals emanating from the 
electrical source and the at least one active electrode to 
determine the relative location of the electrical source 
and the relative location of the at least one active 
electrode. 
25. An apparatus for localizing an electrical source within 
at least one passive electrode adapted for placement in the 
the body comprising: 
the body comprising: 
body; 
16 
at least one active electrode adapted for placement on the 
body; 
a signal generator for delivering electrical energy to the at 
least one active electrode; and 
a computer for processing the signals emanating from the 
electrical source and the at least one active electrode to 
determine the relative location of the electrical source 
and the relative location of the at least one active 
electrode. 
26. An apparatus for localizing an electrical source within 
at least one passive electrode adapted for placement in the 
body; 
at least one active electrode adapted for placement in the 
body; 
a signal generator for delivering electrical energy to the at 
least one active electrode; and 
a computer for processing the signals emanating from the 
electrical source and the at least one active electrode to 
determine the relative location of the electrical source 
and the relative location of the at least one active 
electrode. 
27. The apparatus of claim 23, 24, 25, or 26 wherein the 
zs electrical source is located in the heart. 
28. The apparatus of claim 27 wherein the electrical 
source is the site of origin of an arrhythmia. 
29. The apparatus of claim 23, 24, 25, or 26 wherein the 
computer fits the signals emanating from the electrical 
30. The apparatus of claim 23, 24, 25, or 26 wherein the 
computer fits the signals emanating from the at least one 
active electrode to a moving dipole model. 
31. The apparatus of claim 23, 24, 25, or 26 wherein the 
35 computer fits the signals acquired from the passive elec- 
trodes to a moving dipole model. 
32. The apparatus of claim 23, 24, 25, or 26 further 
comprising an isolation amplifier for isolating the signals 
acquired from the passive electrodes; and an amplifier bank 
40 for amplifying the signals acquired from the passive elec- 
trodes. 
33. The apparatus of claim 23, 24, 25, or 26 further 
comprising a low-pass filter for identifying the signals 
emanating from the electrical source. 
34. The apparatus of claim 23, 24, 25, or 26 further 
comprising a lock-in amplifier for identifying signals ema- 
nating from the at least one active electrode. 
35. The apparatus of claim 23, 24, 25, or 26 further 
comprising a display. 
36. An apparatus for delivering ablative energy in the 
vicinity of the location of an electrical source comprising the 
apparatus of claim 23,24,25, or 26 and further comprising 
a source of ablative energy for delivery in the vicinity of the 
at least one active electrode. 
37. The apparatus of claim 36 further comprising a 
catheter. 
38. The apparatus of claim 37 wherein the at least one 
active electrode is located on the catheter. 
39. The apparatus of claim 38 wherein the ablative energy 
40. The apparatus of claim 36 wherein the ablative energy 
is radio frequency electrical energy. 
41. The apparatus of claim 23, 24, 25, or 26 wherein the 
electrical source is located in the brain. 
42. An apparatus for delivering ablative energy in the 
vicinity of the location of an electrical source comprising the 
apparatus of claim 31 and further comprising: 
lo 
the body comprising: 
15 
20 
30 source to a moving dipole model. 
45 
SO 
ss 
60 is delivered through the catheter. 
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an isolation amplifier for isolating the signals acquired 
an amplifier bank for amplifying the signals acquired 
a low-pass filter for identifying the signals originating ’ 
a lock-in amplifier for identifying the signals emanating 
a catheter, wherein the at least one active electrode is 
located on the catheter; 
a source of ablative energy for delivery in the vicinity of 
the at least one active electrode, wherein the ablative 
energy is delivered through the catheter; and 
from the passive electrodes; and 
from the passive electrodes; 
from the electrical source; 
from the at least one active electrode; 
a display. 
* * * * *  
